Paul D. Rubin, Chief Medical Officer at BioAge Labs, Inc. (BIOA), sold 14,866 shares at $12.85 ($191K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $191k BIOA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.85 | 7,433 | $95K | 50.0% |
| 2 | $12.85 | 7,433 | $96K | 50.0% |
| Total | $12.85 avg | 14,866 | $191K | 100% |
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |
| BIOA | SELL | 2025-12-05 | $1.4M | — | Filing → |